The microbiome in patients with atopic dermatitis.

Area of Science:

• Dermatology
• Microbiology
• Immunology

Background:

• The skin hosts a complex microbial ecosystem crucial for epidermal barrier function.
• Cutaneous microorganisms (commensals) interact with the immune system, influencing both innate and adaptive responses.
• Host-commensal interactions affect immune development in infants, potentially impacting conditions like asthma and atopic dermatitis (AD).

Purpose of the Study:

• To explore the role of the cutaneous microbiome in skin health and disease.
• To understand the relationship between microbiome diversity and atopic dermatitis (AD) severity.
• To investigate the therapeutic potential of commensal microorganisms in managing AD.

Main Methods:

• Review of current scientific literature on the cutaneous microbiome and its role in skin disorders.
• Analysis of studies correlating microbiome composition with disease severity in atopic dermatitis (AD).
• Examination of clinical data from early studies on topical application of commensal bacteria for AD treatment.

Main Results:

• A decrease in skin microbiome diversity correlates with increased severity of atopic dermatitis (AD).
• Reduced microbiome diversity is associated with higher colonization rates of pathogenic bacteria, such as Staphylococcus aureus.
• Early clinical evidence suggests that applying commensal skin bacteria can reduce AD severity and decrease S. aureus colonization.

Conclusions:

• The cutaneous microbiome plays a significant role in the development and progression of skin diseases like AD.
• Commensal microorganisms hold therapeutic promise for managing AD by counteracting pathogenic bacteria.
• Further research into the skin microbiome could lead to novel treatment strategies for atopic dermatitis and other skin disorders.